BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verbrugge I, Maas C, Heijkoop M, Verheij M, Borst J. Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation. Cell Death Differ 2010;17:551-61. [DOI: 10.1038/cdd.2009.141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Al Subeh ZY, Poschel DB, Redd PS, Klement JD, Merting AD, Yang D, Mehta M, Shi H, Colson YL, Oberlies NH, Pearce CJ, Colby AH, Grinstaff MW, Liu K. Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth In Vivo. ACS Nano 2022. [PMID: 35939651 DOI: 10.1021/acsnano.2c04420] [Reference Citation Analysis]
2 Lossi L. The concept of intrinsic versus extrinsic apoptosis. Biochem J 2022;479:357-84. [PMID: 35147165 DOI: 10.1042/BCJ20210854] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
3 Ivanisenko NV, Seyrek K, Hillert-Richter LK, König C, Espe J, Bose K, Lavrik IN. Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks. Trends Cancer 2021:S2405-8033(21)00250-8. [PMID: 34973957 DOI: 10.1016/j.trecan.2021.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hawkins CJ, Miles MA. Mutagenic Consequences of Sublethal Cell Death Signaling. Int J Mol Sci 2021;22:6144. [PMID: 34200309 DOI: 10.3390/ijms22116144] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Humphreys L, Espona-Fiedler M, Longley DB. FLIP as a therapeutic target in cancer. FEBS J 2018;285:4104-23. [PMID: 29806737 DOI: 10.1111/febs.14523] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
6 Micheau O, Shirley S, Dufour F. Death receptors as targets in cancer. Br J Pharmacol 2013;169:1723-44. [PMID: 23638798 DOI: 10.1111/bph.12238] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 15.1] [Reference Citation Analysis]
7 Chen JJ, Shen HC, Rivera Rosado LA, Zhang Y, Di X, Zhang B. Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells. Oncotarget 2012;3:833-42. [PMID: 22909995 DOI: 10.18632/oncotarget.542] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
8 Amelio I, Melino G. The "Sharp" blade against HIF-mediated metastasis. Cell Cycle 2012;11:4530-5. [PMID: 23187809 DOI: 10.4161/cc.22820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhao HT, Wang ZY, Cheng CL, Ma FM, Yang X, Yao L. UV Protective Effect of Anthocyanin Extract from <i>Lonicera caerulea</i> var. Edulis. AMM 2012;195-196:1294-9. [DOI: 10.4028/www.scientific.net/amm.195-196.1294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Koncz G, Hueber AO. The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells. Front Immunol 2012;3:207. [PMID: 22848207 DOI: 10.3389/fimmu.2012.00207] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
11 Villa-Morales M, Fernández-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16:85-101. [PMID: 22239437 DOI: 10.1517/14728222.2011.628937] [Cited by in Crossref: 92] [Cited by in F6Publishing: 101] [Article Influence: 9.2] [Reference Citation Analysis]
12 Darding M, Meier P. IAPs: guardians of RIPK1. Cell Death Differ 2012;19:58-66. [PMID: 22095281 DOI: 10.1038/cdd.2011.163] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 6.2] [Reference Citation Analysis]
13 Niemoeller OM, Belka C. Radiotherapy and TRAIL for cancer therapy. Cancer Lett 2013;332:184-93. [PMID: 21824725 DOI: 10.1016/j.canlet.2011.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
14 Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell. 2011;43:432-448. [PMID: 21737329 DOI: 10.1016/j.molcel.2011.06.006] [Cited by in Crossref: 531] [Cited by in F6Publishing: 619] [Article Influence: 48.3] [Reference Citation Analysis]
15 Liang BC. Increased expression but not sensitivity to Fas/CD95 in glioblastoma cells depleted of mitochondrial DNA. Exp Ther Med 2010;1:1049-55. [PMID: 22993639 DOI: 10.3892/etm.2010.158] [Reference Citation Analysis]
16 Stagni V, Mingardi M, Santini S, Giaccari D, Barilà D. ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and TRAIL-induced apoptosis. Carcinogenesis 2010;31:1956-63. [DOI: 10.1093/carcin/bgq193] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
17 Verheij M, Vens C, van Triest B. Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective. Drug Resistance Updates 2010;13:29-43. [DOI: 10.1016/j.drup.2010.01.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]